Clinical Trial Update: Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating safety and efficacy of ADDERALL XR in adolescents with ADHD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Adderall XR (mixed amphetamine salts)

Snippet

Sponsor: Shire | Conditions: ADHD | Phase 3 | Status: COMPLETED